DOI QR코드

DOI QR Code

The Role and Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease

  • Seo, Hong-Seog (Cardiovascular Center, Korea University College of Medicine, Guro Hospital)
  • Published : 2012.03.31

Abstract

Keywords

References

  1. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003;96:793-807. https://doi.org/10.1093/qjmed/hcg134
  2. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288:H2031-41. https://doi.org/10.1152/ajpheart.01058.2004
  3. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005;135:562-6.
  4. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97. https://doi.org/10.1056/NEJMoa032804
  5. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65. https://doi.org/10.1056/NEJM200106283442601
  6. Koenig W, Khuseyinova N, Baumert J, et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984- 2002. Arterioscler Thromb Vasc Biol 2006;26:2745-51. https://doi.org/10.1161/01.ATV.0000248096.62495.73
  7. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-908. https://doi.org/10.1056/NEJMoa0707402
  8. Devaraj S, Jiala I. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol 2011;31:1397-402. https://doi.org/10.1161/ATVBAHA.111.225508
  9. Pepys MB, Hirschfield GM, Tennent GA, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006;440: 1217-21. https://doi.org/10.1038/nature04672
  10. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207. https://doi.org/10.1056/NEJMoa0807646
  11. Jonathan Emberson, Derrick Bennett, Emma Link, et al. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study. Lancet 2011; 377:469-76. https://doi.org/10.1016/S0140-6736(10)62174-5
  12. Ahmed K, Jeong MH, Chakraborty R, et al. Prognostic impact of baseline high-sensitivity C-reactive protein in patients with acute myocardial infarction undergoing percutaneous coronary intervention based on body mass index. Korean Circ J 2012;42:164-72. https://doi.org/10.4070/kcj.2012.42.3.164
  13. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;122:2748-64.

Cited by

  1. Incremental predictive value of high-sensitivity C-reactive protein for incident hypertension: the Hypertension-Diabetes Daegu Initiative study* vol.36, pp.5, 2012, https://doi.org/10.3109/10641963.2013.810236
  2. Long pentraxin PTX3 mediates acute inflammatory responses against pneumococcal infection vol.493, pp.1, 2012, https://doi.org/10.1016/j.bbrc.2017.08.133
  3. Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019–2020 vol.171, pp.None, 2012, https://doi.org/10.1016/j.bios.2020.112703
  4. Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.782569
  5. Elevated Lipoprotein-Associated Phospholipase A2 is Valuable in Prediction of Coronary Slow Flow in Non-ST-Segment Elevation Myocardial Infarction Patients vol.46, pp.3, 2012, https://doi.org/10.1016/j.cpcardiol.2020.100596
  6. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study vol.13, pp.4, 2012, https://doi.org/10.3390/toxins13040244